China's NMPA Approves Satri-Cel, the World's First CAR-T Therapy for a Solid Tumor, in Advanced Gastric Cancer
CARsgen's Claudin18.2-directed CAR-T satri-cel won Chinese approval for pretreated gastric cancer, becoming the first CAR-T cleared for any solid tumor.